Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-13

Clinical Trial Update: Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Octenisept for chronic wounds was terminated; the update provides no efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Octenisept (octenidine dihydrochloride; phenoxyethanol)

Snippet

Sponsor: Schülke & Mayr GmbH | Conditions: Ulcus Cruris | Phase 4 | Status: TERMINATED